Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Profit After Tax (2018 - 2025)

Historic Profit After Tax for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $24.3 million.

  • TransMedics' Profit After Tax rose 47682.64% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.8 million, marking a year-over-year increase of 18127.03%. This contributed to the annual value of $35.5 million for FY2024, which is 24184.11% up from last year.
  • Per TransMedics' latest filing, its Profit After Tax stood at $24.3 million for Q3 2025, which was up 47682.64% from $34.9 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Profit After Tax registered a high of $34.9 million during Q2 2025, and its lowest value of -$25.4 million during Q3 2023.
  • Moreover, its 5-year median value for Profit After Tax was -$2.6 million (2023), whereas its average is $786000.0.
  • As far as peak fluctuations go, TransMedics' Profit After Tax crashed by 24233.77% in 2023, and later soared by 131818.18% in 2024.
  • Over the past 5 years, TransMedics' Profit After Tax (Quarter) stood at -$12.7 million in 2021, then surged by 46.95% to -$6.7 million in 2022, then skyrocketed by 159.99% to $4.0 million in 2023, then soared by 71.0% to $6.9 million in 2024, then skyrocketed by 252.81% to $24.3 million in 2025.
  • Its Profit After Tax stands at $24.3 million for Q3 2025, versus $34.9 million for Q2 2025 and $25.7 million for Q1 2025.